טוען...
Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis
BACKGROUND: Surgery remains the only curative option for patients with colorectal cancer liver metastases (CRLM). Perioperative chemotherapeutic strategies have become increasingly popular in the treatment of CRLM. Although the role of bevacizumab (Bev) in this setting remains unclear, its widesprea...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Blackwell Publishing Ltd
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2814402/ https://ncbi.nlm.nih.gov/pubmed/20495643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1477-2574.2009.00119.x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|